Statin use and risk of cutaneous melanoma: A nationwide nested case-control study
Br J Dermatol
.
2023 Mar 3;ljad057.
doi: 10.1093/bjd/ljad057.
Online ahead of print.
Authors
Reza Ghiasvand
1
2
3
,
Leon A M Berge
4
1
3
,
Bettina K Andreassen
1
,
Adele C Green
5
6
,
Marie Al Rahmoun
7
,
Agnès Fournier
7
,
Marina Kvaskoff
7
,
Marit B Veierød
4
,
Trude E Robsahm
1
3
Affiliations
1
Department of Research, Cancer Registry of Norway, Oslo, Norway.
2
Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
3
Institute for Cancer Research, Oslo University Hospital, Norway.
4
Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway.
5
QIMR Berghofer Medical Research Institute, Brisbane, Australia.
6
CRUK Manchester Institute, University of Manchester, Manchester, UK.
7
Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP, F-94805, Villejuif, France.
PMID:
36866569
DOI:
10.1093/bjd/ljad057
No abstract available